Discounted Cash Flow
Trulieve Cannabis Corp.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2019 | $252.8m | $0 | $-52.8m | 0.0% | $0.48 |
| 2020 | $521.5m (106.3%) | $0 | $-298.0k (99.4%) | 0.0% | $0.55 (15.1%) |
| 2021 | $938.4m (79.9%) | $-587.0k | $-263.0m (-88156.4%) | -0.1% | $0.14 (-74.9%) |
| 2022 | $1.2b (32.1%) | $-6.7m (-1035.1%) | $-141.7m (46.1%) | -0.5% (-759.1%) | $-1.09 (-884.6%) |
| 2023 | $1.1b (-8.9%) | $-5.1m (22.8%) | $161.5m (214.0%) | -0.5% (15.2%) | $-2.31 (-111.4%) |
| 2024 | $1.2b (5.1%) | $-5.5m (-6.3%) | $150.0m (-7.1%) | -0.5% (-1.2%) | $-0.82 (64.7%) |
| 2025 | $1.2b (-0.4%) | $-5.9m (-7.2%) | $228.6m (52.5%) | -0.5% (-7.7%) | $-0.61 (25.2%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.